These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 10601048)

  • 1. Expression of CD44 variants and prognosis in oesophageal squamous cell carcinoma.
    Gotoda T; Matsumura Y; Kondo H; Ono H; Kanamoto A; Kato H; Watanabe H; Tachimori Y; Nakanishi Y; Kakizoe T
    Gut; 2000 Jan; 46(1):14-9. PubMed ID: 10601048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CD44 variants and its association with survival in pancreatic cancer.
    Gotoda T; Matsumura Y; Kondo H; Saitoh D; Shimada Y; Kosuge T; Kanai Y; Kakizoe T
    Jpn J Cancer Res; 1998 Oct; 89(10):1033-40. PubMed ID: 9849582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. survivin messenger RNA expression is a good prognostic biomarker for oesophageal carcinoma.
    Ikeguchi M; Kaibara N
    Br J Cancer; 2002 Oct; 87(8):883-7. PubMed ID: 12373603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological significance of expression of CD44 variants in head and neck squamous cell carcinoma.
    Kanke M; Fujii M; Kameyama K; Kanzaki J; Tokumaru Y; Imanishi Y; Tomita T; Matsumura Y
    Jpn J Cancer Res; 2000 Apr; 91(4):410-5. PubMed ID: 10804289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of E-cadherin in oesophageal carcinomas from the UK and China: disparities in prognostic significance.
    Jian WG; Darnton SJ; Jenner K; Billingham LJ; Matthews HR
    J Clin Pathol; 1997 Aug; 50(8):640-4. PubMed ID: 9301546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of hypoxia-inducible-factor 1alpha(HIF-1alpha) in oesophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage.
    Kurokawa T; Miyamoto M; Kato K; Cho Y; Kawarada Y; Hida Y; Shinohara T; Itoh T; Okushiba S; Kondo S; Katoh H
    Br J Cancer; 2003 Sep; 89(6):1042-7. PubMed ID: 12966423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of c-Met and CD44v6 Expression in Resistance to Chemotherapy in Esophageal Squamous Cell Carcinoma.
    Hara T; Makino T; Yamasaki M; Tanaka K; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Matsuura N; Mori M; Doki Y
    Ann Surg Oncol; 2019 Mar; 26(3):899-906. PubMed ID: 30610559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of CD44 standard and variant isoforms during the development and progression of uterine cervical tumours.
    Saegusa M; Hashimura M; Machida D; Okayasu I
    J Pathol; 1999 Jan; 187(2):173-83. PubMed ID: 10365092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis.
    Ropponen KM; Eskelinen MJ; Lipponen PK; Alhava E; Kosma VM
    Scand J Gastroenterol; 1998 Mar; 33(3):301-9. PubMed ID: 9548625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic significance of RCAS1 expression in squamous cell carcinoma of the oesophagus.
    Nakakubo Y; Hida Y; Miyamoto M; Hashida H; Oshikiri T; Kato K; Suzuoki M; Hiraoka K; Ito T; Morikawa T; Okushiba S; Kondo S; Katoh H
    Cancer Lett; 2002 Mar; 177(1):101-5. PubMed ID: 11809537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44v3 and v6 variant isoform expression correlates with poor prognosis in early-stage vulvar cancer.
    Tempfer C; Sliutz G; Haeusler G; Speiser P; Reinthaller A; Breitenecker G; Vavra N; Kainz C
    Br J Cancer; 1998 Oct; 78(8):1091-4. PubMed ID: 9792156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma.
    Uchida S; Shimada Y; Watanabe G; Li ZG; Hong T; Miyake M; Imamura M
    Br J Cancer; 1999 Mar; 79(7-8):1168-73. PubMed ID: 10098753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD44 variant isoforms in head and neck squamous cell carcinoma progression.
    Wang SJ; Wong G; de Heer AM; Xia W; Bourguignon LY
    Laryngoscope; 2009 Aug; 119(8):1518-30. PubMed ID: 19507218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival.
    Endo K; Terada T
    J Hepatol; 2000 Jan; 32(1):78-84. PubMed ID: 10673070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44 variant isoform expression and breast cancer prognosis.
    Tokue Y; Matsumura Y; Katsumata N; Watanabe T; Tarin D; Kakizoe T
    Jpn J Cancer Res; 1998 Mar; 89(3):283-90. PubMed ID: 9600122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas.
    Berner HS; Suo Z; Risberg B; Villman K; Karlsson MG; Nesland JM
    Histopathology; 2003 Jun; 42(6):546-54. PubMed ID: 12786890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression status of CD44 and CD133 as a prognostic marker in esophageal squamous cell carcinoma treated with neoadjuvant chemotherapy followed by radical esophagectomy.
    Okamoto K; Ninomiya I; Ohbatake Y; Hirose A; Tsukada T; Nakanuma S; Sakai S; Kinoshita J; Makino I; Nakamura K; Hayashi H; Oyama K; Inokuchi M; Nakagawara H; Miyashita T; Hidehiro T; Takamura H; Fushida S; Ohta T
    Oncol Rep; 2016 Dec; 36(6):3333-3342. PubMed ID: 27748881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of EphA2 and EphrinA-1 expression in oesophageal squamous cell carcinoma.
    Xu F; Zhong W; Li J; Shanshen Z; Cui J; Nesland JM; Suo Z
    Anticancer Res; 2005; 25(4):2943-50. PubMed ID: 16080548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1 and retinoblastoma protein expression in oesophageal squamous cell carcinoma.
    Chetty R; Chetty S
    Mol Pathol; 1997 Oct; 50(5):257-60. PubMed ID: 9497916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer.
    Lim SH; Hong M; Ahn S; Choi YL; Kim KM; Oh D; Ahn YC; Jung SH; Ahn MJ; Park K; Zo JI; Shim YM; Sun JM
    Eur J Cancer; 2016 Jan; 52():1-9. PubMed ID: 26623522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.